A final discussion point is real-world applicability. Although PHAROS presents exceptional PFS, the modest difference between ...
A China-developed KRAS inhibitor led to objective responses in half of patients with previously treated KRAS-mutant non-small cell lung cancer (NSCLC), a prospective non-randomized trial showed.
Medical research is essential for advancing the understanding of health, diseases, and treatments. There are many types of studies that serve different purposes. Medical research, or health research, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results